S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:ETON

Eton Pharmaceuticals Insider Trades

$4.22
-0.10 (-2.31%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$4.08
$4.27
50-Day Range
$4.22
$6.59
52-Week Range
$4.03
$10.30
Volume
141,413 shs
Average Volume
404,672 shs
Market Capitalization
$103.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.26

Eton Pharmaceuticals (NASDAQ:ETON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.71%

Number Of
Insiders Buying
(Last 12 Months)
1

Amount Of
Insider Buying
(Last 12 Months)
$29.80 K

Number Of
Insiders Selling
(Last 12 Months)
2

Amount Of
Insider Selling
(Last 12 Months)
$17.38 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ETON Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eton Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Eton Pharmaceuticals (NASDAQ ETON) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2021Opaleye Management Inc.Major ShareholderSell25,000$4.67$116,750.00  
11/15/2021Opaleye Management Inc.Major ShareholderSell3,000$4.80$14,400.00  
11/8/2021Opaleye Management Inc.Major ShareholderSell52,661$6.10$321,232.10  
11/5/2021Opaleye Management Inc.Major ShareholderSell167,701$6.30$1,056,516.30  
11/3/2021Opaleye Management Inc.Major ShareholderSell116,500$6.53$760,745.00  
10/11/2021Opaleye Management Inc.Major ShareholderSell34,101$5.01$170,846.01  
10/8/2021Opaleye Management Inc.Major ShareholderSell43,692$5.00$218,460.00  
8/6/2021Opaleye Management Inc.Major ShareholderSell345,000$5.84$2,014,800.00  
8/4/2021Opaleye Management Inc.Major ShareholderSell104,000$5.75$598,000.00  
6/3/2021Sean BrynjelsenCEOBuy5,000$5.96$29,800.001,030,000  
5/27/2021Opaleye Management Inc.Major ShareholderSell126,000$8.49$1,069,740.00  
5/25/2021Opaleye Management Inc.Major ShareholderSell48,000$8.53$409,440.00  
4/12/2021Harrow Health, Inc.Major ShareholderSell1,518,000$7.00$10,626,000.001,982,000  
10/16/2020Opaleye Management Inc.Major ShareholderBuy400,000$7.00$2,800,000.00  
8/13/2019Sean BrynjelsenCEOBuy5,000$6.15$30,750.00  
8/9/2019Charles J CasamentoDirectorBuy3,500$6.11$21,385.00  
5/21/2019Sean BrynjelsenCEOBuy10,000$7.93$79,300.00  
11/15/2018Sean BrynjelsenCEOBuy10,000$6.00$60,000.00  
11/15/2018William Wilson TroutmanCFOBuy5,000$6.00$30,000.00  
(Data available from 1/1/2013 forward)












Eton Pharmaceuticals (NASDAQ:ETON) Insider Trade Frequently Asked Questions

Who is on Eton Pharmaceuticals's Insider Roster?

The list of insiders at Eton Pharmaceuticals includes Charles J Casamento, Harrow Health, Inc., Opaleye Management Inc., and Sean Brynjelsen.Learn more on ETON's insiders

What percentage of Eton Pharmaceuticals stock is owned by insiders?

9.71% of Eton Pharmaceuticals stock is owned by insiders. Learn more on ETON's insider holdings

Which Eton Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased Eton Pharmaceuticals stock in the last 24 months: Opaleye Management Inc. ($2,800,000.00), and Sean Brynjelsen ($29,800.00).

How much insider buying is happening at Eton Pharmaceuticals?

Insiders have purchased a total of 405,000 Eton Pharmaceuticals shares in the last 24 months for a total of $2,829,800.00 bought.

Which Eton Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Eton Pharmaceuticals stock in the last 24 months: Harrow Health, Inc. ($10,626,000.00), and Opaleye Management Inc. ($6,750,929.41).

How much insider selling is happening at Eton Pharmaceuticals?

Insiders have sold a total of 2,583,655 Eton Pharmaceuticals shares in the last 24 months for a total of $17,376,929.41 sold.

This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.